Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its commercial portfolio of rare and ultra-rare disease products The agreement will allow ...

Progerinin is an investigational, orally active small-molecule drug being developed as a potential treatment for Hutchinson-Gilford Progeria Syndrome, a rare genetic disorder characterized by ...

Scientists have discovered that a “longevity gene” found in people over 100 years old can protect the heart from the effects of Progeria, a rare genetic disorder that causes children to age rapidly.

You’re reading The New Yorker’s daily newsletter, a guide to our top stories, featuring exclusive insights from our writers and editors. Sign up to receive it in your inbox. For the first time, it ...

In an exciting collaboration set to debut at the 2024 SEMA Show in Las Vegas, RealTruck Inc. has partnered with renowned automotive designer Chip Foose to create a one-of-a-kind truck. The custom 2021 ...

A recent discovery by researchers at the University of Maryland offers hope for new treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disease that causes children to age ...

The results of a University of Maryland (UMD)-led study could point to new and improved treatment approaches for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that causes ...

A University of Maryland-led discovery could spur the development of new and improved treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder with no known cure that causes ...